Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Care Costs | 2 | 2020 | 224 | 0.610 |
Why?
|
| Accountable Care Organizations | 1 | 2021 | 80 | 0.600 |
Why?
|
| Medicare | 2 | 2021 | 629 | 0.580 |
Why?
|
| Patient Readmission | 1 | 2021 | 452 | 0.500 |
Why?
|
| Algorithms | 2 | 2020 | 1060 | 0.450 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 878 | 0.360 |
Why?
|
| Medicare Part D | 4 | 2015 | 36 | 0.340 |
Why?
|
| Hospitalization | 6 | 2021 | 1404 | 0.310 |
Why?
|
| Activities of Daily Living | 3 | 2021 | 295 | 0.310 |
Why?
|
| Male | 31 | 2024 | 31448 | 0.270 |
Why?
|
| United States | 16 | 2021 | 8192 | 0.260 |
Why?
|
| Aged, 80 and over | 13 | 2024 | 5685 | 0.260 |
Why?
|
| Patient Compliance | 4 | 2010 | 370 | 0.250 |
Why?
|
| Aged | 23 | 2024 | 15161 | 0.250 |
Why?
|
| Prostatic Neoplasms | 2 | 2022 | 505 | 0.240 |
Why?
|
| Female | 32 | 2024 | 34470 | 0.240 |
Why?
|
| Physicians, Primary Care | 2 | 2017 | 79 | 0.230 |
Why?
|
| Nursing Homes | 4 | 2021 | 701 | 0.230 |
Why?
|
| Early Detection of Cancer | 4 | 2022 | 327 | 0.230 |
Why?
|
| Breast Neoplasms | 5 | 2022 | 1235 | 0.220 |
Why?
|
| Gout | 4 | 2010 | 48 | 0.220 |
Why?
|
| Medication Adherence | 3 | 2011 | 207 | 0.210 |
Why?
|
| Homes for the Aged | 2 | 2020 | 166 | 0.210 |
Why?
|
| Humans | 39 | 2024 | 65886 | 0.200 |
Why?
|
| Inappropriate Prescribing | 1 | 2024 | 69 | 0.200 |
Why?
|
| Prostate-Specific Antigen | 2 | 2022 | 85 | 0.200 |
Why?
|
| Regression Analysis | 2 | 2020 | 498 | 0.180 |
Why?
|
| Influenza Vaccines | 1 | 2023 | 100 | 0.180 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 463 | 0.170 |
Why?
|
| Dementia | 1 | 2024 | 290 | 0.160 |
Why?
|
| Fractures, Bone | 2 | 2013 | 138 | 0.160 |
Why?
|
| Kallikreins | 1 | 2020 | 9 | 0.160 |
Why?
|
| Diphosphonates | 2 | 2010 | 33 | 0.160 |
Why?
|
| Mobility Limitation | 1 | 2020 | 49 | 0.160 |
Why?
|
| Morbidity | 1 | 2020 | 110 | 0.160 |
Why?
|
| Vaccines | 1 | 2021 | 97 | 0.160 |
Why?
|
| Cystic Fibrosis | 2 | 2011 | 126 | 0.150 |
Why?
|
| Gout Suppressants | 2 | 2010 | 22 | 0.150 |
Why?
|
| Forecasting | 1 | 2020 | 231 | 0.150 |
Why?
|
| Continuity of Patient Care | 2 | 2017 | 175 | 0.140 |
Why?
|
| Middle Aged | 20 | 2024 | 18526 | 0.140 |
Why?
|
| Cardiovascular System | 1 | 2019 | 41 | 0.140 |
Why?
|
| Attitude to Health | 1 | 2020 | 296 | 0.140 |
Why?
|
| Retrospective Studies | 7 | 2021 | 6961 | 0.140 |
Why?
|
| Hospitals | 1 | 2021 | 399 | 0.140 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 2791 | 0.130 |
Why?
|
| Drug Monitoring | 2 | 2009 | 203 | 0.130 |
Why?
|
| Electronic Health Records | 2 | 2020 | 398 | 0.130 |
Why?
|
| Risk Factors | 4 | 2020 | 5478 | 0.130 |
Why?
|
| Reminder Systems | 1 | 2017 | 75 | 0.120 |
Why?
|
| Physicians | 1 | 2022 | 487 | 0.120 |
Why?
|
| Insurance, Health | 2 | 2014 | 153 | 0.120 |
Why?
|
| Antipsychotic Agents | 2 | 2024 | 308 | 0.120 |
Why?
|
| Truth Disclosure | 1 | 2015 | 58 | 0.110 |
Why?
|
| Vaccination | 3 | 2023 | 388 | 0.110 |
Why?
|
| Osteoporosis | 3 | 2010 | 113 | 0.110 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2019 | 370 | 0.110 |
Why?
|
| Adult | 12 | 2024 | 17601 | 0.110 |
Why?
|
| Longitudinal Studies | 5 | 2023 | 1299 | 0.110 |
Why?
|
| Papanicolaou Test | 1 | 2014 | 46 | 0.110 |
Why?
|
| Vaginal Smears | 1 | 2014 | 59 | 0.110 |
Why?
|
| Prospective Studies | 5 | 2024 | 3341 | 0.110 |
Why?
|
| Health Literacy | 1 | 2014 | 95 | 0.100 |
Why?
|
| Bone Density Conservation Agents | 2 | 2010 | 45 | 0.100 |
Why?
|
| Smoking | 2 | 2009 | 864 | 0.100 |
Why?
|
| Medical Errors | 1 | 2015 | 202 | 0.100 |
Why?
|
| Neoplasm Staging | 2 | 2013 | 554 | 0.100 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 155 | 0.100 |
Why?
|
| Health Status | 1 | 2015 | 448 | 0.090 |
Why?
|
| Heart Failure | 1 | 2020 | 968 | 0.090 |
Why?
|
| Databases, Factual | 5 | 2019 | 889 | 0.090 |
Why?
|
| Mammography | 2 | 2022 | 296 | 0.090 |
Why?
|
| Colonoscopy | 1 | 2012 | 97 | 0.090 |
Why?
|
| Drug Utilization | 2 | 2010 | 204 | 0.090 |
Why?
|
| Social Class | 1 | 2012 | 137 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2017 | 726 | 0.080 |
Why?
|
| Tobramycin | 1 | 2011 | 6 | 0.080 |
Why?
|
| Insurance | 1 | 2011 | 18 | 0.080 |
Why?
|
| Deductibles and Coinsurance | 1 | 2010 | 9 | 0.080 |
Why?
|
| Financing, Personal | 1 | 2010 | 23 | 0.080 |
Why?
|
| Pseudomonas Infections | 1 | 2011 | 73 | 0.080 |
Why?
|
| Health Services | 1 | 2011 | 80 | 0.080 |
Why?
|
| Adolescent Behavior | 2 | 2009 | 195 | 0.080 |
Why?
|
| Bone Density | 1 | 2010 | 142 | 0.080 |
Why?
|
| Bone Resorption | 1 | 2010 | 46 | 0.080 |
Why?
|
| Survivors | 2 | 2013 | 189 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 132 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 770 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 2010 | 107 | 0.070 |
Why?
|
| Drugs, Generic | 1 | 2009 | 20 | 0.070 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2009 | 43 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2010 | 79 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2010 | 169 | 0.070 |
Why?
|
| Drug Prescriptions | 1 | 2010 | 165 | 0.070 |
Why?
|
| Massachusetts | 3 | 2024 | 2161 | 0.070 |
Why?
|
| Confidence Intervals | 4 | 2010 | 237 | 0.070 |
Why?
|
| Age Factors | 4 | 2020 | 1595 | 0.070 |
Why?
|
| Proportional Hazards Models | 4 | 2013 | 746 | 0.070 |
Why?
|
| Poverty | 1 | 2010 | 307 | 0.070 |
Why?
|
| Drug Therapy | 1 | 2008 | 56 | 0.070 |
Why?
|
| Health Maintenance Organizations | 1 | 2007 | 61 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2008 | 126 | 0.060 |
Why?
|
| Insurance Claim Review | 1 | 2007 | 76 | 0.060 |
Why?
|
| Students | 1 | 2009 | 227 | 0.060 |
Why?
|
| Family | 1 | 2009 | 251 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 2500 | 0.060 |
Why?
|
| Pandemics | 2 | 2022 | 691 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 558 | 0.060 |
Why?
|
| Cohort Studies | 5 | 2011 | 2653 | 0.060 |
Why?
|
| Drug Administration Schedule | 3 | 2010 | 296 | 0.060 |
Why?
|
| Young Adult | 4 | 2024 | 4887 | 0.060 |
Why?
|
| Time Factors | 4 | 2017 | 3780 | 0.050 |
Why?
|
| Computer Communication Networks | 1 | 2005 | 12 | 0.050 |
Why?
|
| Health Services Accessibility | 2 | 2014 | 604 | 0.050 |
Why?
|
| Adolescent | 6 | 2011 | 6372 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2024 | 32 | 0.050 |
Why?
|
| Deprescriptions | 1 | 2024 | 29 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2024 | 66 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2005 | 70 | 0.050 |
Why?
|
| Medical Informatics | 1 | 2005 | 72 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 289 | 0.050 |
Why?
|
| Registries | 2 | 2005 | 935 | 0.050 |
Why?
|
| Child | 5 | 2011 | 4656 | 0.050 |
Why?
|
| Trust | 1 | 2024 | 82 | 0.050 |
Why?
|
| Health Services Research | 1 | 2005 | 265 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2011 | 2116 | 0.050 |
Why?
|
| Patient Participation | 1 | 2024 | 239 | 0.040 |
Why?
|
| Intention | 1 | 2022 | 74 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2005 | 264 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 489 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 2742 | 0.040 |
Why?
|
| Mass Screening | 2 | 2022 | 700 | 0.040 |
Why?
|
| Michigan | 1 | 2020 | 45 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2020 | 67 | 0.040 |
Why?
|
| Preventive Health Services | 1 | 2020 | 75 | 0.040 |
Why?
|
| Allopurinol | 2 | 2010 | 15 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2020 | 111 | 0.040 |
Why?
|
| Uric Acid | 2 | 2010 | 47 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2020 | 179 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 72 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2019 | 136 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2020 | 310 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2010 | 757 | 0.030 |
Why?
|
| Incidence | 2 | 2013 | 1434 | 0.030 |
Why?
|
| Data Collection | 1 | 2019 | 384 | 0.030 |
Why?
|
| Peer Group | 2 | 2009 | 114 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 932 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 774 | 0.030 |
Why?
|
| Perception | 2 | 2009 | 187 | 0.030 |
Why?
|
| Survival Rate | 2 | 2013 | 849 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1150 | 0.030 |
Why?
|
| Tobacco Use Disorder | 2 | 2009 | 248 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2011 | 2090 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2015 | 47 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 1793 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2015 | 126 | 0.030 |
Why?
|
| Neoplasms | 1 | 2005 | 1379 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2017 | 523 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2007 | 1117 | 0.020 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 142 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 245 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2015 | 430 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 2011 | 41 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 378 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2010 | 76 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 638 | 0.020 |
Why?
|
| Legislation, Drug | 1 | 2010 | 22 | 0.020 |
Why?
|
| Anti-Anxiety Agents | 1 | 2010 | 31 | 0.020 |
Why?
|
| Colchicine | 1 | 2010 | 29 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 505 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 330 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 170 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2010 | 98 | 0.020 |
Why?
|
| Sulfinpyrazone | 1 | 2009 | 2 | 0.020 |
Why?
|
| Probenecid | 1 | 2009 | 5 | 0.020 |
Why?
|
| Income | 1 | 2010 | 169 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 413 | 0.020 |
Why?
|
| Health Expenditures | 1 | 2010 | 122 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2010 | 130 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 371 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 420 | 0.020 |
Why?
|
| Tobacco Industry | 1 | 2008 | 19 | 0.020 |
Why?
|
| Child Behavior | 1 | 2009 | 67 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 202 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2010 | 191 | 0.020 |
Why?
|
| Age of Onset | 1 | 2008 | 175 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 2008 | 42 | 0.020 |
Why?
|
| Commerce | 1 | 2008 | 58 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 859 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2008 | 69 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 806 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2008 | 75 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2007 | 49 | 0.020 |
Why?
|
| Epilepsy | 1 | 2008 | 113 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 995 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 1165 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 745 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2006 | 95 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 106 | 0.010 |
Why?
|
| Logistic Models | 1 | 2009 | 1274 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 809 | 0.010 |
Why?
|
| SEER Program | 1 | 2005 | 76 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1572 | 0.010 |
Why?
|
| Comorbidity | 1 | 2008 | 1122 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 112 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2005 | 117 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 134 | 0.010 |
Why?
|
| Hypertension | 1 | 2008 | 618 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 738 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 5837 | 0.010 |
Why?
|